Sitar Edward J 4
4 · 9 METERS BIOPHARMA, INC. · Filed Jul 2, 2020
Insider Transaction Report
Form 4
Sitar Edward J
Chief Financial Officer
Transactions
- Conversion
Common stock
2020-06-30+67,800→ 67,800 total - Conversion
Series A Convertible Preferred Stock
2020-06-30−678→ 0 totalFrom: 2020-05-04→ Common stock (67,800 underlying)
Footnotes (1)
- [F1]The Series A Convertible Preferred Stock automatically converted to common stock on a 1-to-100 basis upon approval by the Company's stockholders on June 30, 2020.